NBSE
NeuBase Therapeutics, Inc. Common Stock
NBSE
NBSE
Delisted
NBSE was delisted on the 10th of May, 2024.
35 hedge funds and large institutions have $31.1M invested in NeuBase Therapeutics, Inc. Common Stock in 2014 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 10 increasing their positions, 3 reducing their positions, and 0 closing their positions.
Holders
35
Holders Change
+21
Holders Change %
+150%
% of All Funds
1.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
10
Reduced
3
Closed
–
Calls
$32K
Puts
$93K
Net Calls
-$61K
Net Calls Change
-$61K
Top Buyers
Top Sellers
1 |
TRCT
1
Tower Research Capital (TRC)
New York
|
$4K |
2 |
FNBT
2
FineMark National Bank & Trust
Fort Myers,
Florida
|
$54K |
3 |
3
Goldman Sachs
New York
|
$1.85M |